Document is current
Any future updates will be listed below
-
Authors
Van Sanden, Suzy https://orcid.org/0000-0002-9099-1156
Murton, Molly
Bobrowska, Anna
Rahhali, Nora
Sermon, Jan
Rodrigues, Bernardo
Goff-Leggett, Danielle
Chouaid, Christos
Sebastian, Martin
Greystoke, Alastair
-
Funding
Funding for this research was provided by:
Janssen EMEA
- License Information
-
More Information
Article History
Accepted: 3 February 2022
First Online: 28 February 2022
Declarations
:
: This work was funded by Janssen EMEA.
: SVS, NR, JS and BR and employees and shareholders of Janssen EMEA. MS has received personal fees from Amgen, AstraZeneca, Biontech, Bristol Myers Squibb, Boehringer Ingelheim, CureVac, Janssen-Cilag, Merck, MSD, Novartis, Pfizer, Roche, Sanofi-Aventis and Takeda; grants from AstraZeneca; and non-financial support from Bristol Myers Squibb, Pfizer and Takeda. AB, MM and DGL are employees of Costello Medical. CC has received personal fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squib, Eli Lilly, GSK, Janssen, MSD, Novartis, Pfizer, Roche, Sanofi Aventis and Takeda. AG has received personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen/Johnson & Johnson, MSD, Novartis, Pfizer, Roche and Takeda; and research funding from AstraZeneca.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Substantial contributions to study conception and design: SVS, MM, AB, NR, JS, BR, DGL, CC, MS, AG; substantial contributions to analysis and interpretation of the data: SVS, MM, AB, NR, JS, BR, DGL, CC, MS, AG; drafting the article or revising it critically for important intellectual content: SVS, MM, AB, NR, JS, BR, DGL, CC, MS, AG; final approval of the version of the article to be published: SVS, MM, AB, NR, JS, BR, DGL, CC, MS, AG.
